BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 8758673)

  • 41. Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials.
    Eselgrim M; Grunert H; Kühne T; Zoubek A; Kevric M; Bürger H; Jürgens H; Mayer-Steinacker R; Gosheger G; Bielack SS
    Pediatr Blood Cancer; 2006 Jul; 47(1):42-50. PubMed ID: 16206218
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients.
    Le Deley MC; Guinebretière JM; Gentet JC; Pacquement H; Pichon F; Marec-Bérard P; Entz-Werlé N; Schmitt C; Brugières L; Vanel D; Dupoüy N; Tabone MD; Kalifa C;
    Eur J Cancer; 2007 Mar; 43(4):752-61. PubMed ID: 17267204
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment results of pediatric osteosarcoma: twenty-year experience.
    Varan A; Yazici N; Aksoy C; Gedikoğlu G; Yalçin B; Akyüz C; Kutluk T; Büyükpamukçu M
    J Pediatr Orthop; 2007 Mar; 27(2):241-6. PubMed ID: 17314654
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Long-term results of combined therapy for primary osteosarcoma in extremities].
    Cai Y; Niu X; Zhang Q; Hao L; Liu W; Yu F
    Zhonghua Wai Ke Za Zhi; 2000 May; 38(5):329-31. PubMed ID: 11832048
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment results of osteosarcoma of the extremity in children and adolescents at Ege University Hospital.
    Kantar M; Cetingül N; Azarsíz S; Kansoy S; Sabah D; Memiş A; Başdemir G; Burak Z
    Pediatr Hematol Oncol; 2002; 19(7):475-82. PubMed ID: 12217193
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate].
    Sasaki K; Matsuoka H; Murakami T; Fujimoto T; Takayanagi F; Sawai K; Niwa J; Hara K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1837-45. PubMed ID: 3486634
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
    Meyers PA; Schwartz CL; Krailo MD; Healey JH; Bernstein ML; Betcher D; Ferguson WS; Gebhardt MC; Goorin AM; Harris M; Kleinerman E; Link MP; Nadel H; Nieder M; Siegal GP; Weiner MA; Wells RJ; Womer RB; Grier HE;
    J Clin Oncol; 2008 Feb; 26(4):633-8. PubMed ID: 18235123
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prognostic factors for 72 patients with osteosarcoma of the extremity treated with neoadjuvant chemotherapy].
    Liu J; Guo W; Yang RL; Tang XD; Yang Y
    Zhonghua Wai Ke Za Zhi; 2008 Aug; 46(15):1166-70. PubMed ID: 19094683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139.
    Zalupski MM; Rankin C; Ryan JR; Lucas DR; Muler J; Lanier KS; Budd GT; Biermann JS; Meyers FJ; Antman K
    Cancer; 2004 Feb; 100(4):818-25. PubMed ID: 14770440
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity.
    Link MP; Goorin AM; Miser AW; Green AA; Pratt CB; Belasco JB; Pritchard J; Malpas JS; Baker AR; Kirkpatrick JA
    N Engl J Med; 1986 Jun; 314(25):1600-6. PubMed ID: 3520317
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Developments in the treatment of osteosarcoma since 1979. Report of the statistics at the Centre Léon-Bérard].
    Brunat-Mentigny M; Biron P; Kohler R; Blondet R; Bérard J; Chauvot P; Bouffet E; Carret JP; Jonas P; Patricot LM
    Bull Cancer; 1990; 77(9):933-40. PubMed ID: 2224166
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adjuvant therapy for osteosarcoma: preoperative and postoperative treatment.
    Eilber FR; Grant T; Morton DL
    Cancer Treat Rep; 1978 Feb; 62(2):213-6. PubMed ID: 346209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Perioperative chemotherapy for primary sarcoma of bone.
    Chan KW; Knowling M; Beauchamp CP
    Can J Surg; 1989 Jan; 32(1):43-6. PubMed ID: 2910379
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Osteosarcoma of the extremities metastatic at presentation. Results obtained with primary chemotherapy followed by simultaneous resection of the primary and metastatic lesion].
    Bacci G; Briccoli A; Ferrari S; Ruggieri P; Avella M; Casadei R; Battistini A; Picci P
    Minerva Chir; 1993 Jan; 48(1-2):35-45. PubMed ID: 8464555
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overall results of adjuvant chemotherapy and a chemosensitivity test for osteosarcoma.
    Tomita K; Tsuchiya H; Nomura S
    Clin Ther; 1989; 11(1):135-42. PubMed ID: 2720724
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Rationale of preoperative chemotherapy of osteosarcoma].
    Furuse K; Maeyama I; Morimoto K; Orito T; Okuno M
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1392-8. PubMed ID: 3473975
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neoadjuvant chemotherapy for malignant fibrous histiocytoma of bone and for osteosarcoma of the limbs: a comparison between the results obtained for 21 and 144 patients, respectively, treated during the same period with the same chemotherapy protocol.
    Bacci G; Mercuri M; Ruggieri P; Ferraro A; Bertoni F; Tella G; Ferrari S; Iantorno D
    Chir Organi Mov; 1996; 81(2):139-53. PubMed ID: 8968117
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Conservative surgical treatment in osteogenic sarcoma of the limbs].
    Guerra A; Bacci G; Gherlinzoni F
    Rev Chir Orthop Reparatrice Appar Mot; 1985; 71(7):463-71. PubMed ID: 3867102
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin.
    Bacci G; Picci P; Ferrari S; Ruggieri P; Casadei R; Tienghi A; Brach del Prever A; Gherlinzoni F; Mercuri M; Monti C
    Cancer; 1993 Dec; 72(11):3227-38. PubMed ID: 8242546
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Osteosarcoma chemotherapy effect: a prognostic factor.
    Raymond AK; Chawla SP; Carrasco CH; Ayala AG; Fanning CV; Grice B; Armen T; Plager C; Papadopoulos NE; Edeiken J
    Semin Diagn Pathol; 1987 Aug; 4(3):212-36. PubMed ID: 3313606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.